In a new report, researchers at the Medical University of South Carolina have uncovered one of the mechanisms regulating the production of nitric oxide (NO) in liver endothelial cells. A protein complex, centered around beta-arrestin2, modulates endothelial nitric oxide synthase activity and may provide a novel therapeutic target to restore NO production following liver injury.
- Cause of Alzheimer’s disease traced to mutation in common enzyme
- Elkhorn coral actively fighting off diseases on reef, study finds
- Mary Ann Liebert, Inc. to publish Journal of Correctional Health Care
- Exploring the source of stars and planets in a laboratory
- Fipronil, a common insecticide, disrupts aquatic communities in the U.S.